What is Lifestance Health Group, Inc.'s earnings per share (EPS)?

Lifestance Health Group, Inc. (LFST) reported diluted earnings per share of $0.02 for fiscal year 2025. This represents a 113.3% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Lifestance Health Group, Inc. Financials

LFST

Source SEC Filings (10-K/10-Q) Updated Mar 31, 2026 Currency USD FYE December

This page shows Lifestance Health Group, Inc. (LFST) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 6 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI LFST FY2025 2026-05-07

LifeStance’s turnaround is being driven by cash conversion and fixed-cost absorption, not by new borrowing.

Cash conversion improved before reported earnings did: operating cash flow swung from -$16.9M in FY2023 to $107M in FY2024 while net income remained negative. By FY2025, free cash flow of $110M still far exceeded net income of $9.7M, which implies the turnaround was showing up first in collections and cash discipline rather than only in GAAP profit.

The income statement shows a real cost reset: operating margin improved from -17.9% in FY2023 to 1.7% in FY2025. Because SG&A was lower in FY2025 than FY2023 despite a much larger revenue base, the margin gain looks tied to cost discipline and scale covering overhead more efficiently.

Balance-sheet conservatism is real on debt, but less so on asset quality: goodwill of $1.29B represented about 58.7% of assets in FY2025. So the 0.2x debt-to-equity ratio flatters the cushion somewhat; much of reported equity is acquisition value rather than cash or hard operating assets.

Financial Health Signals

Financial Profile 40/100

Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →

Health score ≠ stock price. This rates the quality of Lifestance Health Group, Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

Lifestance Health Group, Inc. has an operating margin of 1.7%, meaning the company retains $2 of operating profit per $100 of revenue. This below-average margin results in a low score of 14/100, suggesting thin profitability after operating expenses. This is up from -2.5% the prior year.

Growth

Lifestance Health Group, Inc.'s revenue grew 13.9% year-over-year to $1.4B, a solid pace of expansion. This earns a growth score of 60/100.

Leverage

Lifestance Health Group, Inc. carries a low D/E ratio of 0.17, meaning only $0.17 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 98/100, indicating a strong balance sheet with room for future borrowing.

Liquidity

Lifestance Health Group, Inc.'s current ratio of 1.65 is below the typical benchmark, resulting in a score of 29/100. However, the company holds substantial cash reserves (99% of current liabilities), which buffers actual liquidity risk. Large mature operators often run tight current ratios by design.

Cash Flow

Lifestance Health Group, Inc. has a free cash flow margin of 7.7%, earning a moderate score of 37/100. The company generates positive cash flow after capital investments, but with room for improvement.

Returns

Lifestance Health Group, Inc. generates a 0.6% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 3/100. This is up from -4.0% the prior year.

Altman Z-Score Grey Zone

2.91

Lifestance Health Group, Inc. scores 2.91, placing it in the grey zone between 1.81 and 2.99. The score is driven primarily by a large market capitalization ($3.0B) relative to total liabilities ($682.9M). This signals moderate financial risk that warrants monitoring.

Piotroski F-Score Strong

7/9

Lifestance Health Group, Inc. passes 7 of 9 financial strength tests. All 4 profitability signals pass (positive income, cash flow, and earnings quality), 2 of 3 leverage/liquidity signals pass, both operating efficiency signals pass.

Earnings Quality Cash-Backed

15.12x

For every $1 of reported earnings, Lifestance Health Group, Inc. generates $15.12 in operating cash flow ($146.2M OCF vs $9.7M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage Adequate

2.1x

Lifestance Health Group, Inc. earns $2.1 in operating income for every $1 of interest expense ($24.1M vs $11.7M). This adequate coverage means the company can meet its interest obligations, but has limited cushion if earnings fall.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$1.4B

YoY+13.9%

5Y CAGR+46.3%

Lifestance Health Group, Inc. generated $1.4B in revenue in fiscal year 2025. This represents an increase of 13.9% from the prior year.

EBITDA

$65.8M

YoY+625.6%

5Y CAGR+29.2%

Lifestance Health Group, Inc.'s EBITDA was $65.8M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 625.6% from the prior year.

Net Income

$9.7M

YoY+116.8%

5Y CAGR+11.3%

Lifestance Health Group, Inc. reported $9.7M in net income in fiscal year 2025. This represents an increase of 116.8% from the prior year.

EPS (Diluted)

$0.02

YoY+113.3%

Lifestance Health Group, Inc. earned $0.02 per diluted share (EPS) in fiscal year 2025. This represents an increase of 113.3% from the prior year.

Cash & Balance Sheet

Free Cash Flow

$110.0M

YoY+28.4%

5Y CAGR+109.4%

Lifestance Health Group, Inc. generated $110.0M in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 28.4% from the prior year.

Cash & Debt

$248.6M

YoY+60.9%

5Y CAGR+134.8%

Lifestance Health Group, Inc. held $248.6M in cash against $265.9M in long-term debt as of fiscal year 2025.

Dividends Per Share

N/A

Shares Outstanding

388M

YoY+1.5%

Lifestance Health Group, Inc. had 388M shares outstanding in fiscal year 2025. This represents an increase of 1.5% from the prior year.

Margins & Returns

Gross Margin

N/A

Operating Margin

1.7%

YoY+4.2pp

5Y CAGR-5.5pp

Lifestance Health Group, Inc.'s operating margin was 1.7% in fiscal year 2025, reflecting core business profitability. This is up 4.2 percentage points from the prior year.

Net Margin

0.7%

YoY+5.3pp

5Y CAGR-2.0pp

Lifestance Health Group, Inc.'s net profit margin was 0.7% in fiscal year 2025, showing the share of revenue converted to profit. This is up 5.3 percentage points from the prior year.

Return on Equity

0.6%

YoY+4.6pp

Lifestance Health Group, Inc.'s ROE was 0.6% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 4.6 percentage points from the prior year.

Capital Allocation

R&D Spending

N/A

Share Buybacks

N/A

Capital Expenditures

$36.1M

YoY+67.5%

5Y CAGR+20.3%

Lifestance Health Group, Inc. invested $36.1M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 67.5% from the prior year.

LFST Income Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY19
Revenue	$1.4B+13.9%	$1.3B+18.5%	$1.1B+22.8%	$859.5M+28.8%	$667.5M+214.1%	$212.5M
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$382.2M+5.3%	$363.1M-11.6%	$410.8M+8.7%	$378.0M-12.8%	$433.7M+956.3%	$41.1M
Operating Income	$24.1M+176.4%	-$31.6M+83.3%	-$189.1M+10.0%	-$210.2M+26.6%	-$286.4M-1978.8%	$15.2M
Interest Expense	$11.7M-56.1%	$26.5M+25.0%	$21.2M+6.5%	$19.9M-48.8%	$38.9M+619.4%	$5.4M
Income Tax	$2.7M+1688.2%	-$170K+99.2%	-$20.3M-18.4%	-$17.2M+33.7%	-$25.9M-1274.4%	$2.2M
Net Income	$9.7M+116.8%	-$57.4M+69.2%	-$186.3M+13.6%	-$215.6M+29.8%	-$307.2M-5518.9%	$5.7M
EPS (Diluted)	$0.02+113.3%	$-0.15+70.6%	$-0.51+16.4%	$-0.61+41.9%	$-1.05	N/A

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Revenue	$403.5M+5.6%	$382.2M+5.1%	$363.8M+5.4%	$345.3M+3.7%	$333.0M+2.3%	$325.5M+4.1%	$312.7M+0.1%	$312.3M
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$100.3M+5.9%	$94.8M-0.9%	$95.6M-1.8%	$97.4M+3.1%	$94.4M+0.8%	$93.7M+9.9%	$85.3M-10.4%	$95.2M
Operating Income	$22.3M+23.2%	$18.1M+144.0%	$7.4M+351.2%	-$3.0M-283.9%	$1.6M+51.5%	$1.1M+2153.2%	$47K+100.3%	-$15.9M
Interest Expense	$1.8M-37.6%	$2.9M+2.2%	$2.8M-3.0%	$2.9M-5.6%	$3.1M-67.3%	$9.4M+73.6%	$5.4M-7.0%	$5.8M
Income Tax	$5.5M+56.1%	$3.5M+1.1%	$3.5M+262.5%	-$2.2M+1.3%	-$2.2M-23.5%	-$1.8M-406.8%	$575K-12.3%	$656K
Net Income	$14.2M+22.1%	$11.7M+983.4%	$1.1M+128.4%	-$3.8M-634.7%	$709K+105.1%	-$13.8M-2043.3%	$709K+103.0%	-$23.3M
EPS (Diluted)	$0.04	N/A	$0.00+100.0%	$-0.01	$0.00	N/A	$-0.02+66.7%	$-0.06

LFST Balance Sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY19
Total Assets	$2.2B+4.0%	$2.1B+0.4%	$2.1B-2.9%	$2.2B+12.8%	$1.9B	N/A
Current Assets	$416.2M+33.2%	$312.5M+38.4%	$225.7M-3.2%	$233.2M-12.5%	$266.5M	N/A
Cash & Equivalents	$248.6M+60.9%	$154.6M+96.1%	$78.8M-27.4%	$108.6M-26.6%	$148.0M+4152.5%	$3.5M
Inventory	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	$95.7M-27.4%	$131.8M+5.1%	$125.4M+24.3%	$100.9M+32.6%	$76.1M	N/A
Goodwill	$1.3B0.0%	$1.3B0.0%	$1.3B+1.6%	$1.3B+5.7%	$1.2B	N/A
Total Liabilities	$682.9M+1.6%	$672.0M-1.3%	$681.0M+4.0%	$655.1M+71.5%	$382.1M	N/A
Current Liabilities	$252.0M+10.1%	$228.9M+12.8%	$202.9M+15.3%	$176.0M+50.7%	$116.8M	N/A
Long-Term Debt	$265.9M-5.0%	$279.8M-0.2%	$280.3M+24.5%	$225.1M+43.0%	$157.4M	N/A
Total Equity	$1.5B+5.2%	$1.4B+1.2%	$1.4B-5.9%	$1.5B-1.7%	$1.5B+1028.8%	-$166.4M
Retained Earnings	-$808.6M+1.2%	-$818.3M-7.5%	-$760.8M-32.9%	-$572.6M-60.4%	-$357.1M	N/A

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Total Assets	$2.1B-2.6%	$2.2B+2.6%	$2.1B+0.1%	$2.1B+2.0%	$2.1B-0.6%	$2.1B+0.5%	$2.1B-0.5%	$2.1B
Current Assets	$355.9M-14.5%	$416.2M+15.5%	$360.4M+0.4%	$358.8M+17.8%	$304.6M-2.5%	$312.5M+8.9%	$287.0M+3.3%	$277.7M
Cash & Equivalents	$194.8M-21.7%	$248.6M+21.9%	$203.9M+7.9%	$188.9M+40.6%	$134.3M-13.1%	$154.6M+50.6%	$102.6M+18.0%	$87.0M
Inventory	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Accounts Receivable	$122.9M+28.4%	$95.7M-20.9%	$121.1M-6.5%	$129.5M-7.8%	$140.4M+6.5%	$131.8M-16.7%	$158.2M-5.4%	$167.2M
Goodwill	$1.3B+0.3%	$1.3B0.0%	$1.3B0.0%	$1.3B0.0%	$1.3B0.0%	$1.3B0.0%	$1.3B0.0%	$1.3B
Total Liabilities	$668.5M-2.1%	$682.9M+4.1%	$656.2M-2.5%	$672.9M+3.9%	$647.6M-3.6%	$672.0M+0.2%	$670.8M-2.7%	$689.3M
Current Liabilities	$239.7M-4.9%	$252.0M+10.2%	$228.6M-5.7%	$242.3M+16.8%	$207.4M-9.4%	$228.9M+5.2%	$217.5M-4.5%	$227.7M
Long-Term Debt	$262.5M-1.3%	$265.9M-1.3%	$269.4M-1.3%	$272.9M-1.3%	$276.3M-1.2%	$279.8M+0.3%	$279.1M-0.1%	$279.5M
Total Equity	$1.5B-2.9%	$1.5B+1.9%	$1.5B+1.3%	$1.5B+1.2%	$1.5B+0.7%	$1.4B+0.6%	$1.4B+0.5%	$1.4B
Retained Earnings	-$794.4M+1.8%	-$808.6M+1.4%	-$820.3M+0.1%	-$821.4M-0.5%	-$817.6M+0.1%	-$818.3M-0.9%	-$811.2M-0.7%	-$805.2M

LFST Cash Flow Statement

Metric	FY25	FY24	FY23	FY22	FY21	FY19
Operating Cash Flow	$146.2M+36.3%	$107.3M+735.3%	-$16.9M-132.0%	$52.8M+460.4%	$9.4M-44.7%	$17.0M
Capital Expenditures	$36.1M+67.5%	$21.6M-46.8%	$40.5M-48.9%	$79.3M-16.1%	$94.5M+560.1%	$14.3M
Free Cash Flow	$110.0M+28.4%	$85.7M+249.3%	-$57.4M-116.9%	-$26.5M+68.9%	-$85.1M-3211.6%	$2.7M
Investing Cash Flow	-$36.1M-67.5%	-$21.6M+64.3%	-$60.3M+56.7%	-$139.5M+28.1%	-$194.1M-164.5%	-$73.4M
Financing Cash Flow	-$16.0M-60.4%	-$9.9M-121.0%	$47.4M+0.3%	$47.3M-84.9%	$313.9M+547.6%	$48.5M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Operating Cash Flow	$33.1M-42.5%	$57.6M+110.9%	$27.3M-57.6%	$64.4M+2182.7%	-$3.1M-105.0%	$62.3M+174.3%	$22.7M-48.4%	$44.1M
Capital Expenditures	$10.8M-1.3%	$10.9M+6.0%	$10.3M+32.7%	$7.8M+8.2%	$7.2M+13.8%	$6.3M+24.7%	$5.1M-1.2%	$5.1M
Free Cash Flow	$22.3M-52.1%	$46.6M+174.5%	$17.0M-70.0%	$56.6M+652.1%	-$10.3M-118.3%	$56.0M+217.0%	$17.7M-54.6%	$39.0M
Investing Cash Flow	-$13.9M-27.5%	-$10.9M-6.0%	-$10.3M-32.7%	-$7.8M-8.2%	-$7.2M-13.8%	-$6.3M-24.7%	-$5.1M+1.2%	-$5.1M
Financing Cash Flow	-$73.0M-3724.2%	-$1.9M+5.5%	-$2.0M+1.3%	-$2.0M+79.5%	-$10.0M-145.8%	-$4.1M-100.4%	-$2.0M-41.4%	-$1.4M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	$49.1M	N/A	N/A	N/A	$0	N/A	N/A	N/A

LFST Financial Ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY19
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	1.7%+4.2pp	-2.5%+15.4pp	-17.9%+6.5pp	-24.4%+18.4pp	-42.9%-50.1pp	7.2%
Net Margin	0.7%+5.3pp	-4.6%+13.1pp	-17.6%+7.4pp	-25.1%+20.9pp	-46.0%-48.7pp	2.7%
Return on Equity	0.6%+4.6pp	-4.0%+9.1pp	-13.0%+1.2pp	-14.2%+5.7pp	-19.9%	N/A
Return on Assets	0.4%+3.1pp	-2.7%+6.1pp	-8.8%+1.1pp	-9.9%+6.0pp	-15.9%	N/A
Current Ratio	1.65+0.3	1.37+0.3	1.11-0.2	1.33-1.0	2.28	N/A
Debt-to-Equity	0.17-0.0	0.190.0	0.20+0.0	0.15+0.0	0.10	N/A
FCF Margin	7.7%+0.9pp	6.9%+12.3pp	-5.4%-2.4pp	-3.1%+9.7pp	-12.7%-14.0pp	1.3%

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	5.5%+0.8pp	4.7%+2.7pp	2.0%+2.9pp	-0.9%-1.3pp	0.5%+0.1pp	0.3%+0.3pp	0.0%+5.1pp	-5.1%
Net Margin	3.5%+0.5pp	3.0%+2.8pp	0.3%+1.4pp	-1.1%-1.3pp	0.2%+4.4pp	-4.2%-4.5pp	0.2%+7.7pp	-7.4%
Return on Equity	1.0%+0.2pp	0.8%+0.7pp	0.1%+0.3pp	-0.3%-0.3pp	0.1%+1.0pp	-1.0%-1.0pp	0.1%+1.7pp	-1.6%
Return on Assets	0.7%+0.1pp	0.5%+0.5pp	0.1%+0.2pp	-0.2%-0.2pp	0.0%+0.7pp	-0.7%-0.7pp	0.0%+1.1pp	-1.1%
Current Ratio	1.48-0.2	1.65+0.1	1.58+0.1	1.48+0.0	1.47+0.1	1.37+0.0	1.32+0.1	1.22
Debt-to-Equity	0.180.0	0.170.0	0.180.0	0.190.0	0.190.0	0.190.0	0.190.0	0.20
FCF Margin	5.5%-6.7pp	12.2%+7.5pp	4.7%-11.7pp	16.4%+19.5pp	-3.1%-20.3pp	17.2%+11.6pp	5.7%-6.8pp	12.5%

Similar Companies

Acadia Healthcar ACHC

$2.5B

Addus Homecare Corp ADUS

$1.7B

Amedisys Inc AMED

$3.3B

Surgery Partners Inc SGRY

$1.9B

CONCENTRA GROUP HOLDINGS PAREN CON

$3.4B

Frequently Asked Questions

What is Lifestance Health Group, Inc.'s annual revenue?

Lifestance Health Group, Inc. (LFST) reported $1.4B in total revenue for fiscal year 2025. This represents a 13.9% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Lifestance Health Group, Inc.'s revenue growing?

Lifestance Health Group, Inc. (LFST) revenue grew by 13.9% year-over-year, from $1.3B to $1.4B in fiscal year 2025.

Is Lifestance Health Group, Inc. profitable?

Yes, Lifestance Health Group, Inc. (LFST) reported a net income of $9.7M in fiscal year 2025, with a net profit margin of 0.7%.

What is Lifestance Health Group, Inc.'s EBITDA?

Lifestance Health Group, Inc. (LFST) had EBITDA of $65.8M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does Lifestance Health Group, Inc. have?

As of fiscal year 2025, Lifestance Health Group, Inc. (LFST) had $248.6M in cash and equivalents against $265.9M in long-term debt.

What is Lifestance Health Group, Inc.'s operating margin?

Lifestance Health Group, Inc. (LFST) had an operating margin of 1.7% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Lifestance Health Group, Inc.'s net profit margin?

Lifestance Health Group, Inc. (LFST) had a net profit margin of 0.7% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is Lifestance Health Group, Inc.'s return on equity (ROE)?

Lifestance Health Group, Inc. (LFST) has a return on equity of 0.6% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Lifestance Health Group, Inc.'s free cash flow?

Lifestance Health Group, Inc. (LFST) generated $110.0M in free cash flow during fiscal year 2025. This represents a 28.4% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Lifestance Health Group, Inc.'s operating cash flow?

Lifestance Health Group, Inc. (LFST) generated $146.2M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Lifestance Health Group, Inc.'s total assets?

Lifestance Health Group, Inc. (LFST) had $2.2B in total assets as of fiscal year 2025, including both current and long-term assets.

What are Lifestance Health Group, Inc.'s capital expenditures?

Lifestance Health Group, Inc. (LFST) invested $36.1M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How many shares does Lifestance Health Group, Inc. have outstanding?

Lifestance Health Group, Inc. (LFST) had 388M shares outstanding as of fiscal year 2025.

What is Lifestance Health Group, Inc.'s current ratio?

Lifestance Health Group, Inc. (LFST) had a current ratio of 1.65 as of fiscal year 2025, which is generally considered healthy.

What is Lifestance Health Group, Inc.'s debt-to-equity ratio?

Lifestance Health Group, Inc. (LFST) had a debt-to-equity ratio of 0.17 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Lifestance Health Group, Inc.'s return on assets (ROA)?

Lifestance Health Group, Inc. (LFST) had a return on assets of 0.4% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Lifestance Health Group, Inc.'s Altman Z-Score?

Lifestance Health Group, Inc. (LFST) has an Altman Z-Score of 2.91, placing it in the Grey Zone (moderate risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Lifestance Health Group, Inc.'s Piotroski F-Score?

Lifestance Health Group, Inc. (LFST) has a Piotroski F-Score of 7 out of 9, indicating strong financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Lifestance Health Group, Inc.'s earnings high quality?

Lifestance Health Group, Inc. (LFST) has an earnings quality ratio of 15.12x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Lifestance Health Group, Inc. cover its interest payments?

Lifestance Health Group, Inc. (LFST) has an interest coverage ratio of 2.1x, meaning it can adequately cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Lifestance Health Group, Inc.?

Lifestance Health Group, Inc. (LFST) scores 40 out of 100 on our Financial Profile, indicating moderate overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.